This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Khoo, D. H. C. Articles by Vassart, G. Search for Related Content PubMed PubMed Citation Articles by Khoo, D. H. C. Articles by Vassart, G.

A Germline Mutation of the Thyrotropin Receptor Gene Associated with Thyrotoxicosis and Mitral Valve Prolapse in a Chinese Family

Department of Endocrinology, Singapore General Hospital (D.H.C. S.C.H.), and the Department of Medicine, Alexandra Hospital (C.R.), Singapore; and Institut de Recherche Interdisciplinaire, Universite Libre de Bruxelles (J.P., G.V.), Brussels, Belgium

Address all correspondence and requests for reprints to: Dr. Daphne Khoo, Department of Endocrinology, Singapore General Hospital, Block 6, Level 6, Outram Road, Singapore 169608. E-mail: daphne_khoo{at}sgh.gov.sg

Activating mutations of the TSH receptor (TSH-R) have been reported to result in toxic adenomas, multinodular goiters, sporadic neonatal hyperthyroidism, and familial autosomal dominant nonautoimmune hyperthyroidism. To date, all descriptions of such mutations, whether somatic or genomic, have been confined to the Caucasian population. We describe a Chinese family in whom a germline proline to serine substitution in position 639 resulted in familial thyrotoxicosis. This constitutively activating mutation has been previously described in a hyperfunctioning thyroid nodule. The three children in this family developed thyrotoxicosis during childhood; their father was diagnosed as thyrotoxic at the age of 38 yr. Two of the children and the father had mitral valve prolapse (MVP) associated with mitral regurgitation. There was a close temporal relationship between the onset of thyrotoxicosis and the diagnosis of mitral valvular disease in these patients. An increased prevalence of MVP has been reported in Graves’ disease and chronic lymphocytic thyroiditis, but the pathophysiological mechanisms linking MVP and autoimmune thyroid disease are still not understood. This is the first report of an association between activating TSH-R mutations and MVP. We postulate that TSH-R activation may increase the clinical expression of MVP in genetically predisposed individuals.

This article has been cited by other articles:

				M A S Rahman, G Birrell, H Stewart, H Lucraft, and T D Cheetham Successful radioiodine treatment in a 3 year old child with Graves' disease following antithyroid medication induced neutropenia Arch. Dis. Child., February 1, 2003; 88(2): 158 - 159. [Abstract] [Full Text] [PDF]

				H. Biebermann, T. Schoneberg, C. Hess, J. Germak, T. Gudermann, and A. Gruters The First Activating TSH Receptor Mutation in Transmembrane Domain 1 Identified in a Family with Nonautoimmune Hyperthyroidism J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4429 - 4433. [Abstract] [Full Text] [PDF]

				S. C. Ho, J. Van Sande, A. Lefort, G. Vassart, and S. Costagliola Effects of Mutations Involving the Highly Conserved S281HCC Motif in the Extracellular Domain of the Thyrotropin (TSH) Receptor on TSH Binding and Constitutive Activity Endocrinology, July 1, 2001; 142(7): 2760 - 2767. [Abstract] [Full Text] [PDF]

				H. Koshiyama, D. F. Sellitti, S. Q. Doi, T. Akamizu, and K. Nakao Comment on Thyrotropin Receptor Gene and Mitral Valve Prolapse J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3404a - 3405. [Full Text]